Lilly, with new data, seeks emergency clearance for COVID-19 antibody drug
Bio Pharma Dive
OCTOBER 7, 2020
The pharma is the first to seek emergency approval for this kind of treatment, and may quickly follow up with a second request after reporting promising data for a two-drug combination.
Let's personalize your content